文献速递神经创伤神经重症

比较去骨瓣减压术中水密硬脑膜修补与非水密硬脑膜修补两种技术的随机对照研究

Randomized controlled study comparing 2 surgical techniques for decompressive craniectomy: with watertight duraplasty and without watertight duraplasty.
PubMed 文献 · J Neurosurg · 2017-11-17

该前瞻性随机对照试验将58例需行单侧去骨瓣减压术的患者随机分为水密硬脑膜修补组(对照组)和非水密硬脑膜修补组(试验组),每组29例,最终试验组27例、对照组28例纳入分析。两组手术并发症发生率无显著差异,但试验组平均手术时间缩短31分钟(101分钟 vs 132分钟,p=0.001),每例总费用平均减少420.00美元(降幅23.4%)。作者认为非水密硬脑膜修补的快速闭合去骨瓣减压术是安全的手术方式。

要点

  • 非水密硬脑膜修补组手术并发症(脑脊液漏、伤口感染、脑脓肿、帽状腱膜下积液)发生率与对照组无显著差异。
  • 非水密硬脑膜修补组平均手术时间为101分钟,对照组为132分钟,缩短31分钟(p=0.001)。
  • 非水密硬脑膜修补组每例总费用平均减少420.00美元,降幅为23.4%。

核心结论

  • 非水密硬脑膜修补的快速闭合去骨瓣减压术是安全的手术方式,不增加手术并发症发生率,并平均缩短手术时间31分钟、每例减少费用420.00美元(降幅23.4%)。

研究设计与样本

  • 前瞻性随机对照试验,研究对象为18至60岁在Hospital da Restauração神经创伤科因临床指征接受单侧去骨瓣减压术的患者,采用编号信封随机分为水密硬脑膜修补组(对照组)和非水密硬脑膜修补组(试验组)。
  • 共纳入58例患者,每组29例;排除3例后,试验组27例、对照组28例纳入分析。
  • 主要终点为手术并发症(脑脊液漏、伤口感染、脑脓肿或帽状腱膜下积液)的发生率;次要终点包括临床结局(采用格拉斯哥结局量表GOS分析)、手术时间和住院费用。

主要发现

  • 两组在年龄、手术时格拉斯哥昏迷量表评分、GOS评分及术后随访天数方面无显著差异。
  • 共发生9例手术并发症,其中对照组5例、试验组4例,两组间无显著差异。
  • 对照组平均手术时间为132分钟,试验组为101分钟,差异为31分钟(p=0.001)。
  • 试验组每例总费用平均减少420.00美元(降幅23.4%)。

临床怎么用

  • 作者认为非水密硬脑膜修补的快速闭合去骨瓣减压术是安全的手术方式。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Decompressive craniectomy (DC) is a widely used procedure in neurosurgery; however, few studies focus on the best surgical technique for the procedure. The authors' objective was to conduct a prospective randomized controlled trial comparing 2 techniques for performing DC: with watertight duraplasty and without watertight duraplasty (rapid-closure DC). METHODS: The study population comprised patients ranging in age from 18 to 60 years who were admitted to the Neurotrauma Service of the Hospital da Restauração with a clinical indication for unilateral decompressive craniectomy. Patients were randomized by numbered envelopes into 2 groups: with watertight duraplasty (control group) and without watertight duraplasty (test group). After unilateral DC was completed, watertight duraplasty was performed in the control group, while in the test group, no watertight duraplasty was performed and the exposed parenchyma was covered with Surgicel and the remaining dura mater. Patients were then monitored daily from the date of surgery until hospital discharge or death. The primary end point was the incidence of surgical complications (CSF leak, wound infection, brain abscess, or subgaleal fluid collections). The following were analyzed as secondary end points: clinical outcome (analyzed using the Glasgow Outcome Scale [GOS]), surgical time, and hospital costs. RESULTS: Fifty-eight patients were enrolled, 29 in each group. Three patients were excluded, leaving 27 in the test group and 28 in the control group. There were no significant differences between groups regarding age, Glasgow Coma Scale score at the time of surgery, GOS score, and number of postoperative follow-up days. There were 9 surgical complications (5 in the control group and 4 in the test group), with no significant differences between the groups. The mean surgical time in the control group was 132 minutes, while in the test group the average surgical time was 101 minutes, a difference of 31 minutes (p = 0.001). The mean reduction in total cost was $420.00 USD (a 23.4% reduction) per procedure in the test group. CONCLUSIONS: Rapid-closure DC without watertight duraplasty is a safe procedure. It is not associated with a higher incidence of surgical complications (CSF leak, wound infection, brain abscess, or subgaleal fluid collections), and it decreased surgical time by 31 minutes on average. There was also a hospital cost reduction of $420.00 USD (23.4% reduction) per procedure. Clinical trial registration no.: NCT02594137 (clinicaltrials.gov).

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Vieira E, Guimarães TC, Faquini IV, et al. Randomized controlled study comparing 2 surgical techniques for decompressive craniectomy: with watertight duraplasty and without watertight duraplasty. J Neurosurg. 2017. PMID: 29148904. doi:10.3171/2017.4.JNS152954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。